North Carolina · 87637

Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus in North Carolina

North Carolina Medicare Avg
$139.16
0% below national avg
National Medicare Avg
$139.61
All states combined
Billed Charge (NC)
$232.02
What providers submit
Est. Commercial (NC)
$303.36
National avg: $312.73
Est. Cash / Self-Pay (NC)
$168.17
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

7.4K
Services in NC
202
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in North Carolina

Provider Medicare Services
Laboratory Corporation Of America... $139.55 3.2K
Andor Labs $139.78 321
Laboratory Corporation Of America... $139.78 242
Baker, David M.D. $138.02 159
United Providers Of Health $139.78 86
Burnette, J MD, F.A.C.P. $137.85 79

North Carolina Pricing in Context

In North Carolina, CPT code 87637 (Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus) carries an average Medicare payment of $139.16 — 0% below the national benchmark of $139.61. 202 providers across the state submitted claims for this procedure in 2023, performing 7.4K total services. Individual payments in NC ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in North Carolina is $232.02, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because North Carolina sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Laboratory procedures, the estimated commercial insurance price in North Carolina lands near $303.36, with self-pay cash prices typically around $168.17. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus cost in North Carolina?

The average Medicare payment for Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus in North Carolina is $139.16, which is 0% below the national average of $139.61. Providers in NC typically bill $232.02 for this procedure.

What does Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus cost with insurance in North Carolina?

With commercial insurance in North Carolina, Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus costs an estimated $303.36. Without insurance, the estimated cash price is $168.17. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus in North Carolina?

202 providers in North Carolina billed Medicare for Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus in 2023, performing 7.4K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus cheaper in North Carolina than the national average?

Yes — Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus costs 0% below the national average in North Carolina. The state average Medicare payment is $139.16 compared to $139.61 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial